Accutane Injury Attorney in Kansas City

Accutane Claims and Lawsuits

If you or someone you know has taken or is currently taking Accutane or any form of isotretinoin and has experienced serious side effects, it is important to seek medical attention and consult with a lawyer at our offices. A Kansas City pharmaceutical litigation attorney can offer you guidance in regard to your legal options if you have suffered Accutane side effects.

Accutane is an oral medication prescribed to treat severe acne. The generic form of this drug is isotretinoin. It is a derivative of vitamin A. Isotretinoin is known under other brand names, including Amnesteem, Claravis, Decutan, Isotret, Ortane and Sotret. These are all oral forms of the medication, but it may be available in topical forms as well. Accutane was originally developed as part of a chemotherapy treatment for brain cancer and other cancerous growths.

Although there are various side effects that a person may experience when taking Accutane, there are some side effects that are very serious and may have a dramatic impact on the patient's life. These serious side effects include: depression, hair loss, hepatitis, pancreatitis, suicidal thoughts, psychosis and inflammatory bowel disease. At this time, Accutane is only available to patients through iPLEDGE, a program developed to eliminate fetal exposure to isotretinoin. A doctor may only prescribe Accutane after a patient passes the iPLEDGE qualifications and may only prescribe a 30-day supply at a time, with a new iPLEDGE application required with every new prescription.

Kansas City Drug Injury Lawyer

If you or a loved one has suffered any side effects related to Accutane use or any other form of isotretinoin, make sure you consult with a drug injury lawyer at our Kansas City law firm at your earliest convenience. You may have grounds for a lawsuit. By reviewing the matter and discussing your options with you, we can determine the best approach.

Contact a Kansas City Accutane Lawsuit Lawyer at Wendt Goss, P.C. today.